Wire Stories

Canterbury Park Holding Corporation Reports Record 2021 Third Quarter Results

SHAKOPEE, Minn., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Canterbury Park Holding Corporation (�Canterbury� or the �Company�) (NASDAQ: CPHC), today reported…

4 years ago

Proactive news headlines including Tesla, MGX Minerals, Bragg Gaming, Clean Air Metals, Harbor Custom Development and CytoDyn

New York , Nov. 08, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies…

4 years ago

- Q702 is a novel, orally available triple kinase inhibitor that selectively targets Axl, Mer, and CSF1R - A phase…

4 years ago

RMIT Turns to HPE GreenLake to Increase Agility and Adapt to Dynamic Education and Research Opportunities

RMIT University adopts HPE GreenLake to meet increasing demand for online learning and growth of its essential research HPE GreenLake…

4 years ago

Studio City International Holdings Limited Announces Unaudited Third Quarter 2021 Earnings

MACAU, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (�Studio City� or the �Company�), a…

4 years ago

Zai Lab and Blueprint Medicines Announce Strategic Collaboration and License Agreement for BLU-945 and BLU-701 in Greater China

-- Zai Lab obtains exclusive rights to develop and commercialize BLU-945 and BLU-701 in Greater China -- -- Collaboration accelerates…

4 years ago

BIO-key adds Cyber Threat Intelligence Services, Cyberlitica to Channel Alliance Partner Program, Helping Customers Address Core Aspects of a Holistic Cybersecurity Program

WALL, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access…

4 years ago

Gilat Reports Strong Revenue & Profitability Growth in Third Quarter 2021

Revenue up 34% year-over-year to $49.9M, GAAP operating income of $0.9 million and Adjusted EBITDA reached $4.0 million PETAH TIKVA,…

4 years ago

Zai Lab and Karuna Therapeutics Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China

Zai Lab obtains exclusive rights to develop and commercialize KarXT in Greater China Karuna to receive upfront cash payment of…

4 years ago

-- Broad Product Pipeline Expands Both Vertically and Horizontally with Three New Potential First-in-Class or Best-in-Class Medicines -- Company to…

4 years ago
Show more Posts
Show previous Posts